Approximately 100 infectious diseases were identified for preliminary consideration (Table 2.1), including the four diseases specified in the legislation that directs the committee’s work (Box 2.1).

TABLE 2.1 Diseases and Etiologic Agents Considered by the Committee for Evaluation

Disease

Etiologic Agent

Bacterial diseases

 

Acinetobacter infection

Acinetobacter baumanii and other Acinetobacter species

Actinomycosis

Actinomyces spp.

Anthrax

Bacillus anthracis

Bartonellosis

Bartonella spp.

Cat-scratch disease

B. henselae

Trench fever

B. quintana

Botulism

Clostridium botulinum

Brucellosis

Brucella spp.

Campylobacteriosis

Campylobacter spp.

Capnocytophaga infection

Capnocytophaga spp.

Chlamydia

 

Genital infections

Chlamydia trachomatis

Pneumonia

Chlamydia pneumoniae

Cholera (including vibrio infections)

Vibrio spp.

Diphtheria

Corynebacterium diphtheriae

E. coli gastroenteritis

Escherichia coli

 

Enterotoxigenic E. coli

 

Shiga toxin-producing E. coli

 

Enteroaggregative E. coli

 

Enteroinvasive E. coli

 

Enterohemorrhagic E. coli

 

Enteropathogenic E. coli

Ehrlichioses

Ehrlichia spp.

Enteric fever

 

Paratyphoid fever

Salmonella enterica serovar Paratyphi A,B,C

Typhoid fever

Salmonella enterica serovar Typhi

Enterococcal infection (vancomycin-resistant)

Enterococcus spp.

Gas gangrene

Clostridium perfringens

Hemophilus meningitis

Haemophilus influenzae

Helicobacter infection

Helicobacter pylori

Klebsiella infection

Klebsiella spp.

Legionnaire’s disease

Legionella spp.

Leptospirosis

Leptospira spp.

Listeriosis

Listeria monocytogenes

Lyme disease

Borrelia burgdorferi

Melioidosis

Burkholderia pseudomallei

Meningococcal infection

Neisseria meningitidis

Moraxella infection

Moraxella catarrhalis



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement